Gl. Caporaso et al., Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia, NEUROPHARM, 39(9), 2000, pp. 1637-1644
ARPP-21 is a cyclic AMP-regulated phosphoprotein of M-r 21 kDa that is enri
ched in the cell bodies and terminals of medium-sized spiny neurons in the
basal ganglia. Using a new phosphorylation state-specific antibody selectiv
e for the detection of ARPP-21 phosphorylated on Ser(55), we have demonstra
ted that activation of dopamine D1 receptors increased the level of ARPP-21
phosphorylation in mouse striatal slices. Conversely, activation of D2 rec
eptors caused a large decrease in ARPP-21 phosphorylation. Treatment of mic
e with either methamphetamine or cocaine resulted in increased ARPP-21 phos
phorylation in vivo. Studies using specific inhibitors of protein phosphata
ses and experiments in mice bearing a targeted deletion of the gene for DAR
PP-32, a dopamine-activated inhibitor of protein phosphatase-1, indicated t
hat protein phosphatase-2A is primarily responsible for dephosphorylation o
f ARPP-21 in mouse striatum. These results demonstrate that phosphorylation
and dephosphorylation of ARPP-21 are tightly regulated in the striatum. We
speculate that ARPP-21 might mediate some of the physiologic effects of do
pamine and certain drugs of abuse in the basal ganglia. (C) 2000 Elsevier S
cience Ltd. All rights reserved.